Managing Side Effects and Monitoring in ER-Positive, HER2-Negative Metastatic Breast Cancer

In this segment, Dr. Gregory Vidal discusses practical steps patients can take to manage side effects while undergoing treatment for ER-positive, HER2-negative metastatic breast cancer. He emphasizes the importance of open communication with the care team and encourages patients to report new or worsening symptoms early rather than waiting for scheduled visits. Dr. Vidal explains that many side effects associated with endocrine therapy or combination treatments can be proactively managed through dose adjustments, supportive medications, or lifestyle modifications. He also highlights the critical role of regular monitoring, including laboratory testing and imaging, to assess treatment effectiveness and ensure patient safety. Routine follow-up allows clinicians to detect disease progression or treatment-related toxicities promptly and make necessary adjustments. This segment reinforces that effective management of ER-positive, HER2-negative metastatic breast cancer requires ongoing partnership between patients and their care teams to maintain both disease control and quality of life.